PSC INC
S-3, 1997-08-29
COMPUTER PERIPHERAL EQUIPMENT, NEC
Previous: FIDELITY INTERNATIONAL LTD, SC 13D/A, 1997-08-29
Next: NIKE INC, 10-K, 1997-08-29






    As filed with the Securities and Exchange Commission on August ___, 1997
                                               Registration No. 33-________


                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM S-3

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                                    PSC INC.
             (Exact name of Registrant as specified in its charter)


           New York                                          16-0969362
(State or other jurisdiction of            (IRS Employer Identification Number)
incorporation or organization)

                                 675 Basket Road
                             Webster, New York 14580
                                (716) 265-1600
   (Address, including  zip  code,  and telephone number, including  area code,
           of Registrant's principal executive office)

                              Robert C. Strandberg
                      President and Chief Executive Officer
                                    PSC Inc.
                                 675 Basket Road
                                Webster, NY 14580
                            Telephone: (716) 265-1600
(Name, address, including zip code, and telephone number, including area code, 
                             of agent for service)


                                   Copies to:

                           Martin S. Weingarten, Esq.
                Boylan, Brown, Code, Fowler, Vigdor & Wilson, LLP
                                2400 Chase Square
                               Rochester, NY 14604


Approximate  date of  commencement  of proposed  sale to the public:  As soon as
practicable after this Registration Statement becomes effective.

If any of the  securities  being  registered on this form are to be offered on a
delayed or continuous  basis  pursuant to Rule 415 under the  Securities  Act of
1933, check the following box. [_X_]



<PAGE>




                                    CALCULATION OF REGISTRATION FEE

 Title of each class    Amount   Proposed maximum  Proposed       Amount of
 of securities to be    to be    Offering price    Maximum       registration
    registered        registered   per share(1) Aggregate offering    fee
                                                  Price (1)
    Common Shares, 
    par value        975,000(2)     $6.875     $6,703,125            $2031.25
  $.01 per share, representing
shares issuable upon exercise of
            warrants


(1)  Estimated  solely  for the  purpose of  calculating  the  registration  fee
pursuant  to Rule  457(c)  under the  Securities  Act of 1933 and based upon the
average of the high and low sale prices  reported on the Nasdaq  National Market
on August 26, 1997.

(2) The  number of Common  Shares  specified  above is the  number  which may be
acquired  upon exercise of certain of the  Company's  warrants  described in the
Prospectus forming a part of this Registration Statement (the "Warrants").  This
Registration  Statement  covers,   pursuant  to  Rule  416,  in  addition,  such
indeterminable  number of  Common  Share as may be  issued  on  exercise  of the
Warrants  by reason of  adjustments  in the  number  of Common  Shares  issuable
pursuant  to  antidilution  provisions  contained  in the  Warrants.  Since such
additional   Common  Shares  will,  if  issued,  be  issued  for  no  additional
consideration, no registration fee is required.
                             -----------------------

The Registrant hereby amends this  Registration  Statement on such date or dates
as may be necessary to delay its effective date until the Registrant  shall file
a further amendment which specifically  states that this Registration  Statement
shall  thereafter  become  effective  in  accordance  with  Section  8(a) of the
Securities  Act of  1933  or  until  the  Registration  Statement  shall  become
effective on such date as the Commission,  acting pursuant to said Section 8(a),
may determine.




<PAGE>


PROSPECTUS
                                    PSC INC.
                                                                     

                              975,000 Common Shares
                       Issuable upon Exercise of Warrants


         This Prospectus has been prepared in conjunction  with the distribution
of up to 975,000 Common Shares, $.01 par value (the "Shares"),  of PSC Inc. (the
"Company" or "PSC") issuable upon the exercise of certain  outstanding  warrants
of the  Company  which are  proposed  to be sold  from  time to time by  certain
selling shareholders (the "Selling  Shareholders").  See "Selling Shareholders."
The Company will not receive any of the proceeds  from the sale of the Shares by
the  Selling  Shareholders.  The Company  will  receive  the  proceeds  from the
exercise of the Warrants,  if any, and will use such proceeds,  if any, for debt
reduction and for working capital. As amended, the Warrants are exercisable at a
price of  $8.00  per  share  and may be  exercised  between  July  12,  1997 and
September 15, 2006. The costs and expenses of registering  the Shares covered by
this Prospectus will be paid by the Company.

         The Company's  Common Shares are quoted on the Nasdaq  National  Market
under the symbol PSCX.  On August 26, 1997 the last  reported sale price for the
Common Shares was $6.81 per share.


  The Shares offered hereby involve a high degree of risk. See "Risk Factors."



  THESE  SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
  EXCHANGE COMMISSION OR ANY STATE SECURITIES  COMMISSION NOR HAS THE SECURITIES
  AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED
  UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO 
  THE CONTRARY IS A CRIMINAL OFFENSE.

         The  distribution  of the  Shares by the  Selling  Shareholders  may be
effected from time to time in one or more transactions  (which may involve block
transactions) in the over-the-counter  market, on the Nasdaq National Market (or
any  exchange  on which the Common  Shares may then be  listed),  in  negotiated
transactions  or  otherwise.  Sales will be effected at such prices and for such
consideration  as may be obtainable from time to time.  Commission  expenses and
brokerage fees, if any, will be paid by the Selling  Shareholders.  See "Selling
Shareholders" and "Plan of Distribution."

The date of this Prospectus is August 29, 1997.

<PAGE>



                              AVAILABLE INFORMATION

         The  Company  is  subject  to  the  informational  requirements  of the
Securities  Exchange  Act of 1934,  as  amended  (the  "Exchange  Act"),  and in
accordance therewith files reports,  proxy statements and other information with
the Securities and Exchange Commission (the "Commission").  Such reports,  proxy
statements  and other  information  can be  inspected  and  copied at the public
reference  facilities  maintained  by the  Commission  at Room  1024,  450 Fifth
Street, N.W., Judiciary Plaza, Washington,  D. C. 20549, and at the Commission's
following  Regional  Offices:  Suite 1400,  Northwest  Atrium  Center,  500 West
Madison  Street,  Chicago,  Illinois  60661;  and 13th Floor,  Seven World Trade
Center,  New York,  New York 10048.  Copies of such  material can be obtained at
prescribed  rates from the Public  Reference  Section of the  Commission  at 450
Fifth Street, N.W., Judiciary Plaza, Washington, D.C. 20549. The Commission also
maintains a Web site that contains reports, proxy and information statements and
other  information  regarding  registrants  (including  the  Company)  that file
electronically with the Commission.  The address of the Commission's Web site is
http://www.sec.gov.  In addition,  the Company's Common Shares are listed on the
Nasdaq National Market, and the  aforementioned  materials may also be inspected
at the offices of the Nasdaq Stock Market at 1735 K Street, N.W., Washington, D.
C. 20006.

         The Company has filed a  Registration  Statement  on Form S-3 under the
Securities  Act of 1933, as amended,  with respect to the Common Shares  offered
hereby. This Prospectus does not contain all of the information set forth in the
Registration  Statement  and the  exhibits  and  schedules  thereto  For further
information  with respect to the Company and such Common Shares offered  hereby,
reference is made to the Registration Statement and the exhibits,  schedules and
reports  filed as part thereof.  Statements  contained in this  Prospectus  with
respect to the contents of any contract or other document filed as an exhibit to
the  Registration  Statement  are not  necessarily  complete,  and in each  such
instance reference is hereby made to the copy of such contract or document filed
as an exhibit to the Registration Statement. Each such statement is qualified in
all respects by such reference to such exhibit. Copies of all or any part of the
Registration  Statement,  including  the  documents  incorporated  by  reference
therein or exhibits  thereto,  may be obtained  upon  payment of the  prescribed
rates at the offices of the Commission set forth above.


<PAGE>



                 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

         The  Company's  Annual  Report on Form 10-K for the  fiscal  year ended
December 31, 1996, the Company's Quarterly Reports on Form 10-Q for the quarters
ended April 4, 1997 and July 4, 1997, the Company's  Amended Quarterly Report on
Form 10-Q/A for the quarter ended July 4, 1997, the Company's  Current Report on
Form 8-K filed on May 7, 1997,  the Company's  Proxy  Statement  dated March 31,
1997  and the  description  of the  Company's  Common  Shares  contained  in the
Company's  Registration  Statement  on Form 8-A  filed by the  Company  with the
Commission  on August 31,  1981 are hereby  incorporated  by  reference  in this
Prospectus, except as superseded or modified herein.

         All  documents  filed by the Company  with the  Commission  pursuant to
Section  13(a),  13(c),  14 or 15(d) of the  Exchange Act after the date of this
Prospectus  and prior to the  termination  of the offering of the Shares offered
hereby shall be deemed to be  incorporated by reference into this Prospectus and
to be a part hereof  from the date of filing of such  documents.  Any  statement
contained in any document incorporated or deemed to be incorporated by reference
herein  shall be  deemed to be  modified  or  superseded  for  purposes  of this
Prospectus  to the  extent  that a  statement  contained  herein or in any other
subsequently  filed  documents  which also is or is deemed to be incorporated by
reference  herein  modifies or  supersedes  such  statement.  Any  statement  so
modified or superseded shall not be deemed, except as modified or superseded, to
constitute a part of this Prospectus.

         The Company will provide  without charge to each person,  including any
beneficial  owner,  to whom this  Prospectus is delivered,  upon written or oral
request of such person, a copy of any and all of the documents that have been or
may be incorporated  by reference  herein (other than exhibits to such documents
which are not specifically incorporated by reference into such documents).  Such
requests should be directed to Charis W. Copin,  Director of Investor Relations,
at the Company's  principal  executive offices at 675 Basket Road,  Webster,  NY
14580 (telephone (716) 265-1600).



<PAGE>


                                   THE COMPANY

         PSC Inc., together with its subsidiaries (the "Company"),  manufactures
a  comprehensive  line of laser  based  handheld  and  fixed  position  bar code
readers,  verifiers and integrated  sortation and  point-of-sale  (POS) scanning
systems for the  worldwide  Automatic  Identification  and Data  Capture  (AIDC)
market.  The  Company's  products  serve as the "front end" of terminals or host
computers  and are used to identify,  capture,  process and transmit  data.  The
Company has  developed  products  for AIDC at every stage of the product  supply
chain  from  raw  material,   manufacturing   and  warehousing,   to  logistics,
transportation,  inventory  management and POS. The Company's  products are used
throughout  the world in food and general  retail,  healthcare,  government  and
other industries.

         The Company has  positioned  itself within the AIDC industry by selling
both  domestically  and  internationally.   International  sales  accounted  for
approximately  38%  of  the  Company's  1996  total  sales.  The  Company  has a
diversified customer base composed of original equipment  manufacturers  (OEMs),
third-party  resellers and end users. The Company's  distribution  relationships
have enabled it to introduce its products  (generally  under non-PSC  labels) to
new  vertical   markets,   and  have  fostered  the   development  of  strategic
relationships with leading AIDC participants and end users. The Company operates
within one industry segment:
automatic identification and data capture.

         The Company's corporate headquarters are located in the Rochester,  New
York suburb of Webster. The Company designs,  manufactures,  sells,  distributes
and services its products from manufacturing facilities in Webster, New York and
Eugene,  Oregon.  The Company has sales and service  operations in the Americas,
Europe, Asia and Australia.

         PSC was  incorporated  in the State of New York in 1969.  The Company's
headquarters  are  located  at 675  Basket  Road,  Webster,  New  York,  and its
telephone number is (716) 265-1600.

         Recent   Developments.   On  July  12,  1996,   the  Company   acquired
Spectra-Physics  Scanning  Systems,  Inc.,  TxCom S.A.  and  related  businesses
(collectively  "Spectra") from  Spectra-Physics AB, a multinational  corporation
based in Sweden.  Spectra,  which is headquartered in Eugene,  Oregon, is one of
the worlds' leading manufacturers of countertop and in-counter bar code scanners
for retail point-of-sale applications. The purchase price was approximately $140
million and was paid by $125 million in cash,  $10 million in PSC Common  Shares
and by a $5 million subordinated  promissory note. The $125 million cash portion
was funded by a combination of the Company's  cash,  senior debt ($92.5 million)
and subordinated debt ($30 million).  In connection with the subordinated  debt,
warrants  ("Warrants")  evidencing  rights to purchase an  aggregate  of 975,000
Common  Shares of the  Company  were  issued and sold to the  purchasers  of the
subordinated debt. As amended,  the Warrants have an exercise price of $8.00 per
share and may be exercised between July 12, 1997 and September 15, 2006. Holders
of  the  Warrants  have  certain  rights  relating  to  registration  and to the
repurchase by the Company of the Warrants and the shares issued upon exercise of
the Warrants (the "Warrant Shares") under certain circumstances.



<PAGE>


         On April 30, 1997, L. Michael Hone resigned as Chief Executive Officer,
as Chairman of the Board of Directors, and as a member of the Board of Directors
of the Company. On the same date, Robert S. Ehrlich, formerly the Company's Vice
Chairman,  was elected Chairman of the Board and Robert C. Strandberg,  formerly
the  Company's  Executive  Vice  President,  was  elected  President  and  Chief
Executive Officer of the Company.

         On June 30, 1997, the Company sold all of its shares in Tx Com S.A. to 
Tx Com S.A. for approximately $1.0 million.

Legal Proceedings

         There is pending in the United  States  District  Court for the Western
District of New York (the  "Court") an action (the  "Litigation"),  commenced in
April  1996,  between  the  Company  and Symbol  Technologies,  Inc.  ("Symbol")
relating  to issues of  patent  infringement  and  validity,  antitrust,  unfair
competition,  and the breach of certain license agreements.  See "Risk Factors -
Intellectual Property;  Pending Litigation".  The Litigation is in the discovery
stage.  On October 9, 1996, the Court  determined that there would be a non-jury
hearing (the "Markman  Hearing") as to all of Symbol's patents in suit which, as
agreed by the parties, are now limited to nine patents. The Markman Hearing will
be solely related to claim  construction  of the patent claims alleged by Symbol
to be infringed. Subsequent to the Markman Hearing, it is expected there will be
a jury trial on the issues of infringement and validity. All of the other issues
in the litigation have been stayed pending a  determination  on the nine patents
of Symbol.

         When the Company acquired Spectra in July 1996,  Spectra was a party to
a 1985 License Agreement,  as modified in 1995, with Symbol (the "Symbol-Spectra
License")  which  provided for  arbitration  in accordance  with the  Commercial
Arbitration Rules of the American Arbitration  Association in Chicago,  Illinois
with respect to issues (among others) of which  products may be deemed  licensed
products.

         On March 10, 1997, in accordance with the Symbol-Spectra  License,  the
Company  demanded  arbitration  (the  "Arbitration")  to  determine  whether the
Company  is  entitled  to sell its QS 6000  scan  module  as a  licensed  device
pursuant to the  Symbol-Spectra  License and whether customers who purchase said
module may incorporate it into portable data terminals without fear of suit from
Symbol or need to pay any  royalties  beyond  those  paid by the  Company on the
module itself.

         On May 9, 1997, the Court denied  Symbol's motion to enjoin or stay the
Arbitration,  and  stayed  the  Markman  Hearing  pending  the  outcome  of  the
Arbitration.  The  Arbitration  was held during the week of July 21, 1997 and no
decision has yet been rendered.


<PAGE>


                                  RISK FACTORS

         In addition to the other information in this Prospectus or incorporated
by reference herein,  the following risk factors should be considered  carefully
in evaluating the Company and its business before  purchasing the Shares offered
hereby. This Prospectus contains  forward-looking  statements that involve risks
and  uncertainties.  The Company's actual results may differ  significantly from
the results  discussed  in the  forward-looking  statements.  Factors that could
cause or contribute to such differences  include,  but are not limited to, those
discussed below.

         Substantial  Leverage.  The Company incurred  substantial  indebtedness
($127.5  million) in connection  with the  acquisition of the Spectra.  See "The
Company - Recent  Developments."  The degree to which the  Company is  leveraged
could have  important  consequences  to the holders of the Common Shares offered
hereby,  including the following: (i) the Company's ability to obtain additional
financing in the future for working capital, capital expenditures,  acquisitions
or general corporate purposes may be impaired; (ii) a substantial portion of the
Company's cash flow from operations must be dedicated to the payment of interest
on the  indebtedness,  thereby  reducing the funds  available to the Company for
other  purposes;   (iii)  the  agreements   governing  the  Company's  long-term
indebtedness contain certain restrictive financial and operating covenants; (iv)
certain  indebtedness  under  the  senior  debt  will be at  variable  rates  of
interest,  which  would  cause the  Company to be  vulnerable  to  increases  in
interest rates; (v) all of the indebtedness outstanding under the senior debt is
secured by  substantially  all the assets of the  Company;  (vi) the  Company is
substantially more leveraged than certain of its competitors,  which might place
the Company at a competitive disadvantage;  (vii) the Company may be hindered in
its ability to adjust  rapidly to  changing  market  conditions;  and (viii) the
Company's  substantial  degree of leverage could make it more  vulnerable in the
event of a downturn in general economic conditions or its business.

         Debt Service.  As a result of the  indebtedness  incurred in connection
with the acquisition of the Spectra, a substantial portion of the Company's cash
flow will be devoted to debt  service.  The  ability of the  Company to continue
making  payments of principal  and interest will be largely  dependent  upon its
future  performance.  Many  factors,  some of which will be beyond the Company's
control,  such as prevailing economic  conditions,  will affect its performance.
There can be no assurance  that the Company will be able to generate  sufficient
cash flow to cover required interest and principal  payments.  If the Company is
unable to meet interest and principal  payments in the future, it may, depending
upon  the  circumstances  which  then  exist,  seek  additional  equity  or debt
financing, attempt to refinance its existing indebtedness or sell all or part of
its business or assets to raise funds to repay its indebtedness. There can be no
assurance that  sufficient  equity or debt  financing will be available,  or, if
available,  that it will be on terms acceptable to the Company, that the Company
will be able to refinance its existing  indebtedness  or that  sufficient  funds
could be raised through asset sales. In addition,  the ability of the Company to
raise funds by selling assets is restricted by the Senior Debt.



<PAGE>


         Technological   Change.  The  market  for  the  Company's  products  is
characterized by rapidly changing  technology,  evolving industry  standards and
changing customer needs. The Company's future success will depend on its ability
to enhance  its  current  products,  to  develop  new  products  on a timely and
cost-effective basis and to respond to changing customer needs and technological
developments.  Certain of the  Company's  competitors  spend  larger  amounts on
research and development efforts than the Company. Any failure by the Company to
anticipate  or  respond   adequately  to  changes  in  technology  and  customer
preferences,  or any significant  delay in product  development or introduction,
could have a material  adverse effect on the Company's  financial  condition and
results  of  operations.  There can be no  assurance  that the  Company  will be
successful  in developing  new products or enhancing its existing  products on a
timely  or   cost-effective   basis,  or  that  such  new  products  or  product
enhancements will achieve market acceptance.

         Dependence  on Sales by Third  Parties.  The  Company's  net  sales are
dependent upon the ability of its original equipment manufacturer ("OEM"), value
added reseller ("VAR"),  distributor and systems integrator customers to develop
and sell products that  incorporate the Company's  scanning  products.  Factors,
including  economic  conditions,  patent  positions,  inventory  positions,  the
ability to sell the Company's products to end users, regulatory requirements and
other  marketing  restrictions,  that  adversely  affect the  operations  of the
Company's  OEM, VAR,  distributor  and systems  integrator  customers can have a
substantial impact upon the Company's  financial  results.  No assurances can be
given that the Company's OEM, VAR,  distributor and systems integrator customers
will not experience  financial or other difficulties that could adversely affect
their operations and, in turn, the results of operations of the Company.

         Intellectual  Property;  Pending  Litigation.  The Company's success is
dependent in part on its ability to obtain patent  protection  for its products,
maintain trade secret protection and operate without  infringing the proprietary
rights of  others.  The  Company  currently  owns over 100 U.S.  patents  having
expirations  from the year  2001 to the year 2014 and also has  certain  foreign
patents. The Company has filed, and intends to file, applications for additional
patents  covering  its  products.  There can be no  assurance  that any of these
patent applications will be granted, or that the Company will develop additional
products that are patentable and do not infringe upon the patents of others,  or
that the patents  issued to or licensed by the Company  will provide the Company
with a  competitive  advantage  or  adequate  protection  for its  products.  In
addition,  there can be no assurance  that the  Company's  competitors  will not
develop  technology  or  know-how,  or  obtain  patents,  that  could  limit the
Company's ability to compete in the future or that patents issued to or licensed
by the Company will not be challenged, invalidated or circumvented by others.

         The AIDC industry is characterized by substantial  litigation regarding
patent and other intellectual  property rights. The Company aggressively defends
its patents and other  proprietary  rights.  The Company has commenced an action
against Symbol Technologies, Inc. ("Symbol") for violation of the antitrust laws
and  unfair  trade  practices  and for  declaration  of  noninfringement  and/or
invalidity  of  certain  of  Symbol's  patents.  In  that  action,   Symbol  has
counterclaimed  alleging patent  infringement  and alleging  breaches of certain
Symbol-PSC  License  Agreements.  PSC has informed Symbol that subsequent to the
Spectra acquisition it has been operating under certain Symbol-Spectra  licenses
rather than under the Symbol-PSC licenses. The status of the various licenses is
before the courts.  Although the Company  maintains  that  Symbol's  patents are
invalid,  that the Company has not infringed the patents,  or both, and that the
Symbol-Spectra  License Agreements rather than the Symbol-PSC License Agreements
are  controlling,  there can be no assurance that the actions will be decided or
settled in the Company's  favor.  There can be no assurance that others will not
assert claims against the Company that result in litigation. Any such litigation
could result in significant  expense,  adversely impact the Company's marketing,
give rise to certain  indemnity rights on the part of customers,  and divert the
Company's  attention from other matters.  If any of the Company's  products were
found to  infringe a  third-party  patent,  the third party could be entitled to
injunctive  relief,  which  would  prevent  the  Company  from  selling any such
infringing products. In addition,  the Company could be required to pay monetary
damages.  Although the Company could seek a license to sell products  determined
to infringe a third-party patent, there can be no assurance that a license would
be available on terms acceptable to the Company.  The Company could also attempt
to redesign any infringing  products so as to avoid  infringement,  although any
effort  to do so could be  expensive  and  time-consuming,  and  there can be no
assurance the effect would be successful.

         Competition.  The  AIDC  industry  is  highly  competitive  with  rapid
technological  change,  product  improvements,   new  product  introduction  and
intellectual  property  developments  representing key competitive  factors. The
Company  also  competes  on  the  basis  of  innovative  design,   high  qualify
manufacturing,  technical  expertise  in  scanning,  level of sales and  support
services,  price and overall product  functionality and fitness for use. Failure
to keep pace with product and technological advances could negatively affect the
Company's  competitive  position  and  prospects  for  growth.  Several  of  the
Company's  competitors have substantially  greater financial and other resources
than the Company.  In addition,  other larger  corporations could enter the AIDC
industry.  No  assurance  can be given that the Company  will be able to compete
successfully  against  current and future  competitors  or that the  competitive
factors faced by the Company will not adversely  affect its business,  financial
condition or results of operations.

         Dependence on Key Vendors.  The  Company's  ability to produce and ship
its products on schedule is highly  dependent  on timely  receipt of an adequate
supply of components and materials from its key vendors.  The Company  currently
relies on single  suppliers,  some of whom manufacture at a number of locations,
for some of the key  components of its products.  The Company could incur set-up
costs and delays in  manufacturing  should it become  necessary  to replace  key
vendors due to work stoppages,  shipping delays, financial difficulties or other
factors and,  under certain  circumstances,  these costs and delays could have a
material adverse effect on the Company's business or results of operations.

         Product Transitions.  The Company is dependent upon the introduction of
new and improved products. The Company's financial performance is dependent upon
the successful  introduction of these  products.  The success will be dependent,
among other things,  upon the ability of the Company to complete  development of
certain products,  customer  acceptance of and demand for these products and the
ability of the Company to  efficiently  manufacture  these  products and to meet
delivery  schedules.  The introduction of new and enhanced products requires the
Company  to manage  the  transition  from older  products  in order to  minimize
disruption in customer ordering patterns,  avoid excess levels of older material
inventories and ensure that adequate supplies of new product can be delivered to
meet  customer  demand.  There  can  be  no  assurance  that  the  Company  will
successfully manage the transition to selling new products. The failure to do so
could have a material  adverse  effect on the Company's  business and results of
operations.

         Fluctuations  in  Operating  Results.  Historically,  the  Company  has
experienced  variability  in its  quarterly  results.  Large  orders  can  cause
favorable or  unfavorable  variations in quarterly  comparisons.  The volume and
timing of orders  received  during a quarter are  difficult to  forecast.  Since
customers generally order products for delivery within 30 to 45 days, backlog is
not a reliable  predictor  of future  financial  performance  beyond the current
quarter. In addition,  the Company's results may vary significantly from quarter
to quarter  depending on other factors such as the level of  development,  sales
and marketing expense incurred in anticipation of future revenues and the timing
of new product and  applications  announcements  and releases by the Company and
its  competitors.  Many of these factors are beyond the Company's  control.  The
Company  believes that quarterly  period-to-period  comparisons of its financial
results  are not  necessarily  meaningful  and should  not be relied  upon as an
indication  of future  performance.  The  Company  believes  that,  in  general,
retailers  are  reluctant to install  point-of-sale  scanners  during their peak
fourth quarter selling period. This may have a negative effect on fourth quarter
sales.

         Risks Associated with International Operations.  The Company's sales to
international  customers  increased from $11.2 million or 19% of total net sales
in 1994 to $55.2  million or 38% of net sales in 1996.  The  Company  intends to
continue  to expand its  operations  outside  of the United  States and to enter
additional  international  markets and  expects  that  international  sales will
represent a substantial  portion of its revenues.  This will require significant
management  attention and  financial  resources and will result in a significant
portion of the Company's net sales being  subject to the risks  associated  with
international  sales.  Such risks include  changes in  regulatory  requirements,
compliance costs associated with quality control  standards,  special  standards
requirements,  tariffs and other barriers,  reduced  protection for intellectual
property  rights  in some  countries,  difficulties  in  staffing  and  managing
international  subsidiary  operations,  potentially  adverse  tax  consequences,
country-specific    product    requirements   and   political   and   regulatory
uncertainties. The majority of the Company's sales in Europe and the Pacific Rim
are  billed  in  foreign   currencies  and  are  subject  to  currency  exchange
fluctuations.  Since the  Company's  products  are  manufactured  in the  United
States, sales and results of operations could be impacted by fluctuations in the
U.S  dollar.  There can be no  assurance  that  these  factors  will not have an
adverse   impact  on  the   Company's   ability  to  increase  or  maintain  its
international sales or on the Company's results of operations.


<PAGE>


         Volatility of Stock Price. The Company's Common Shares have experienced
substantial  price  volatility  and such  volatility  may  occur in the  future,
particularly  as a result  of  quarter-to-quarter  variations  in the  actual or
anticipated  financial  results  of  the  Company,  its  competitors  and  other
companies in the AIDC industry.  In addition,  the stock market has  experienced
significant price and volume fluctuations that have affected the market price of
many  technology  companies  and have  often  been  unrelated  to the  operating
performance of these companies.  Broad market  fluctuations,  as well as general
economic and political conditions,  may adversely affect the market price of the
Common Shares.

         Government  Regulation.  The  Company's  products  and  operations  are
subject to regulation by federal,  state and local agencies in the United States
and its products are subject to regulation in certain  foreign  countries  where
the Company's  products are sold.  While the Company  believes that its products
and operations comply with all applicable regulations, there can be no assurance
of continued compliance if these regulations were to change.  Noncompliance with
respect  to these  regulations  could  have a  material  adverse  impact  on the
Company's results of operations.

         Anti-Takeover  Effects of Certain  Charter  and Bylaw  Provisions.  The
Company's  Certificate  of  Incorporation  (the  "Certificate")  and Bylaws (the
"Bylaws") contain certain provisions  relating to corporate  governance,  to the
rights of shareholders,  and to the possible issuance of Preferred Shares. These
provisions may be deemed to have a potential "anti-takeover" effect in that such
provisions  may delay,  defer or prevent a change in control of the  Company and
may  delay or make  more  difficult  a  merger,  tender  offer or proxy  contest
involving the Company. The Certificate provides for the Board of Directors to be
divided into three classes of directors serving staggered three-year terms. As a
result,  approximately  one-third of the Board of Directors will be elected each
year.  In addition,  the  Certificate  provides that  shareholders  may remove a
director only for cause and only by the vote of the holders of two-thirds of the
Common Shares of the Company. This provision, when coupled with the provision of
the  Certificate  authorizing  only  the  Board  of  Directors  to  fill  vacant
directorships,  will preclude  shareholders  from removing  incumbent  directors
without cause and  simultaneously  gaining  control of the Board of Directors by
filling the vacancies created by such removal with their own nominees,  and will
make more  difficult,  and therefore may  discourage,  a proxy contest to change
control of the Company.  The Certificate  also provides that special meetings of
shareholders of the Company may be called only by the Board of Directors.  These
provisions of the Certificate may be changed only by the affirmative vote of the
holders of two-thirds  of the Common  Shares of the Company  entitled to vote on
such matters at a meeting duly called for such purpose.  The Bylaws provide that
shareholders  seeking to bring business before an annual meeting of shareholders
or to nominate  candidates  for  election as  directors  at an annual or special
meeting of shareholders, must provide prior written notice thereof, as set forth
in the Bylaws. The Certificate  provides that the Company's Preferred Shares may
be issued in the future without further shareholder approval and upon such terms
and conditions, and having such rights, privileges and preferences, as the Board
of Directors may determine.



<PAGE>


                                 USE OF PROCEEDS

         All  proceeds  from the sale of the Shares to be sold  pursuant to this
Prospectus  will  be  for  the  account  of  the  Selling  Shareholders.   As  a
consequence,  the Company  will not receive  any  proceeds  from the sale of the
Shares  offered by the  Selling  Shareholders.  The  Company  will  receive  the
proceeds from the exercise of the Warrants by the Selling  Shareholders.  If all
975,000 Warrants are exercised, the Company will receive $7,800,000. The Company
plans to use those proceeds, if any, for debt reduction and for working capital.



<PAGE>


                              SELLING SHAREHOLDERS

         To help fund the Spectra  acquisition,  the Company,  on July 12, 1996,
entered into identical Securities Purchase Agreements the ("Securities  Purchase
Agreements") with six (6) institutional  purchasers (the "Purchasers")  pursuant
to which the Company  issued and sold its 11.25% Senior  Subordinated  Notes due
June 30, 2006 in the aggregate  principal  amount of  $30,000,000.00.  (See "The
Company - Recent Developments.") In connection with this financing,  the Company
issued and sold to the Purchasers warrants ("Warrants") evidencing the rights to
purchase an aggregate of 975,000 Common Shares of the Company which, as amended,
have an exercise  price of $8.00 per share.  The Warrants may be exercised on or
after July 12, 1997 and  terminate  at the close of business  on  September  15,
2006.

         Pursuant to the Securities Purchase Agreements,  the Company granted to
the holders of the  Warrants  certain  registration  rights with  respect to the
underlying shares. In addition,  the holders of the Warrants have certain rights
relating to the  repurchase by the Company of the Warrants and the shares issued
upon  the  exercise  of  the  Warrants.  In  the  event  of (a)  the  merger  or
consolidation  of the Company  into  another  corporation  which does not have a
class of publicly traded equity securities registered under the Exchange Act and
where the  consideration  to be received by the holders of the Company's  Common
Shares in connection with such merger or  consolidation  does not consist solely
of cash payable in full upon  consummation of such merger or  consolidation,  or
(b) the  sale,  transfer  or  other  disposition  by the  Company  of all or any
substantial  part of its  properties  and  assets  to  another  corporation  for
consideration  which (i) is other than (A)  publicly  traded  equity  securities
registered  under the Exchange Act and/or (B) cash and (ii) is then  distributed
to the  shareholders  of the  Company,  then the holders of the Warrants and the
underlying  shares  have the right to  require  the  Company  to  purchase  such
securities.

         The following table summarizes certain  information with respect to the
Selling Shareholders:


                      Number of 
                      Shares              Number    Number of  Percent of Shares
                      Beneficially Owned of Shares  Shares         Outstanding
                      Prior to Offering Registered Beneficially After Offering  
                             (1)          Herein    Owned After         (2)
                                                    Offering (2)
                      
John Hancock Mutual         373,750        373,750            0            --
Life Insurance
Company

John Hancock                 48,750         48,750            0            --
Variable Life
Insurance Company

The Lincoln                 227,500        227,500            0            --
National Life
Insurance Company

Lincoln National             16,250         16,250            0            --
Income Fund, Inc.


ReliaStar Financial          16,250         16,250            0            --
Corp., as successor
to
Security-Connecticut
Corporation

The Equitable Life          292,500        292,500            0            --
Assurance Society
of the United States

(1)  The number of Common  Shares  reflected as  beneficially  owned assumes the
     exercise of the 975,000  Warrants  currently  outstanding  and  exercisable
     within 60 days from the date hereof.

(2)   Assumes all Shares registered herein are sold.



                              PLAN OF DISTRIBUTION

         The Shares may be sold from time to time by the Selling Shareholders or
by pledgees,  donees,  transferees or other  successors in interest.  Such sales
maybe  made  in  any  one  or  more   transactions   (which  may  involve  block
transactions) in the over-the-counter market, on the Nasdaq National Market, and
any  exchange  in which the  Company's  Common  Shares  may then be  listed,  or
otherwise in negotiated  transactions  or a combination of such methods of sale,
at market  prices  prevailing  at the time of sale,  at prices  related  to such
prevailing market prices or at negotiated prices.  The Selling  Shareholders may
effect such transactions by selling Shares to or through broker-dealers and such
broker-dealers may receive  compensation in the form of underwriting  discounts,
concessions or commissions from the Selling  Shareholders  and/or  purchasers of
Shares from whom they may act as agent (which  compensation  may be in excess of
customary commissions).

         The  Company  has   informed   the   Selling   Shareholders   that  the
anti-manipulative rules under the Exchange Act (Rules 10b-6 and 10b-7) may apply
to their sales of Shares in the market.  Also,  the  Company  has  informed  the
Selling  Shareholders  of the need for delivery of copies of the  Prospectus  in
connection with any sale of securities  registered  hereunder in accordance with
applicable prospectus delivery requirements.

         In  connection  with  such  sales,  the  Selling  Shareholders  and any
participating  brokers and dealers may be deemed to be "underwriters" as defined
in the  Securities  Act. In  addition,  any of the Shares that  qualify for sale
pursuant  to Rule 144 may be sold under Rule 144 rather  than  pursuant  to this
Prospectus.

         In order to comply with certain state  securities  laws, if applicable,
the Shares will not be sold in a particular  state unless such  securities  have
been  registered  or  qualified  for  sale in such  state or an  exemption  from
registration or qualification is available and complied with.

         Pursuant to the Securities  Purchase  Agreements,  the Company will use
its best efforts to keep this Registration Statement current and effective for a
period of two years from the effective  date hereof or such shorter  period that
will  terminate  when all  Shares  have  been (i)  disposed  of  pursuant  to an
effective registration  statement, or (ii) sold under circumstances in which all
of the applicable conditions of Rule 144 are met. There can be no assurance that
the Selling Shareholders will sell any or all of the Shares which may be offered
under this Registration Statement.


                                  LEGAL MATTERS

         The validity of the issuance of the Shares being offered hereby will be
passed upon for the Company by Boylan,  Brown,  Code,  Fowler,  Vigdor & Wilson,
LLP,  Rochester,  New York.  Justin L.  Vigdor,  a partner  of this  firm,  is a
director of the Company, and Martin S. Weingarten,  Secretary of the Company, is
counsel  to this  firm.  As of the date of this  Prospectus,  members of Boylan,
Brown, Code, Fowler, Vigdor & Wilson, LLP beneficially own 23,750 Common Shares.


                                     EXPERTS

         The  consolidated  financial  statements and schedules  incorporated by
reference in this  Prospectus and elsewhere in the  Registration  Statement from
the Company's  Annual  Report on Form 10-K for the year ended  December 31, 1996
have been audited by Arthur Andersen LLP,  independent  public  accountants,  as
indicated  in their  reports with respect  thereto,  and are included  herein in
reliance upon the authority of said firm as experts in giving said reports.

         No  person  is  authorized  to give  any  information  or to  make  any
representation,  other than those  contained in or  incorporated by reference in
this  Prospectus,  and any  information or  representations  not contained in or
incorporated  by reference in this  Prospectus must not be relied upon as having
been authorized by the Company or the Selling Shareholders. This Prospectus does
not  constitute  an  offer  to sell or a  solicitation  of an  offer  to buy any
securities  other  than the  registered  securities  to which it  relates.  This
Prospectus does not constitute an offer to sell or a solicitation of an offer to
buy such securities under any circumstances  where such offer or solicitation is
unlawful.  Neither the delivery of this  Prospectus nor any sales made hereunder
shall,  under any  circumstances,  create any implication that there has been no
change  in the  affairs  of the  Company  since  the  date  hereof  or that  the
information contained herein is correct as of any time subsequent to its date.




<PAGE>



                                     PART II

                     INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14. Other Expenses of Issuance and Distribution

                  Set  forth  below is an  estimate  of the  fees  and  expenses
payable by the Registrant in connection with the Offering:

Securities and Exchange Commission registration fee.......    $  2,031.25
Legal fees and expenses.......................................   5,000.00
Accounting fees and expenses..................................   5,000.00
Miscellaneous.................................................   1,000.00
TOTAL......................................................... $13,031.25

Item 15. Indemnification of Directors and Officers

                  Sections 721-726 of the New York Business  Corporation Law, as
amended (the "BCL"),  give New York  corporations the power to indemnify each of
their present and former officers or directors under certain  circumstances,  if
such person acted in good faith and in a manner which he reasonably  believed to
be in, or not opposed to, the best interests of the corporation.

                  The Restated Certificate of Incorporation of the Registrant as
amended,  contains a provision that  eliminates  the personal  liability of each
director to the Registrant or its  shareholders  for monetary damages for breach
of fiduciary duty as a director, except for any breach of the director's duty if
a judgment or other final adjudication adverse to such director establishes that
such  director's  acts or  omissions  were in bad faith or involved  intentional
misconduct  or a  knowing  violation  of law or that  such  director  personally
gained,  in fact, a financial  profit or other  advantage to which such director
was not legally  entitled or that such director's  acts violated  Section 719 of
the BCL.

                  The by-laws of the Registrant contain a provision permitted by
the BCL that provides that  directors  and officers will be  indemnified  by the
Registrant  to the fullest  extent  permitted  by law for all losses that may be
incurred by them in connection with any action, suit or proceeding in which they
may become  involved by reason of their  service as a director or officer of the
Registrant.


<PAGE>


                  The  Registrant  has entered into an indemnity  agreement with
each officer and director to provide  contractual  assurance that the protection
afforded by the Registrant's  by-laws will be available regardless of changes in
the Registrant's charter documents or change in control of the Registrant.

                  The Registrant maintains an officers' and directors' liability
insurance  policy  insuring  the covered  individuals  against acts or omissions
taken by such persons in their capacities as officers or directors.

Item 16. Exhibits

        Exhibit No.                                               Title

            4.1               Form of Certificate for Common Shares of the 
                              Registrant (incorporated by
                              reference to Exhibit 4.3 to the Registrant's 
                              Registration Statement on Form
                              S-3, effective March 24, 1995 (No. 33-89178)).

            4.2               Form of the  11.25%  Senior  Subordinated  Note of
                              SpectraScan,  Inc.,  due June 30, 2006 (Notes were
                              issued  to  seven   Purchasers  in  the  aggregate
                              principal amount of $30,000,000)  (incorporated by
                              reference to Exhibit 4.1 to the Company's  Current
                              Report on Form 8-K dated July 29,  1996 (the "1996
                              8-K")).

            4.3               Form of Note Guarantee dated July 12, 1996 made by
                              PSC Inc. and each of the domestic subsidiaries of 
                              PSC Inc. to each of the purchasers of the Senior
                              Subordinated Notes (incorporated by reference to 
                              Exhibit 4.2 of the 1996 8-K).

            4.4               Form of Warrant issued to the Purchasers  named in
                              the Securities  Purchase Agreements dated July 12,
                              1996 (Warrants were issued to seven Purchasers for
                              an  aggregate  of  975,000  common  shares  of the
                              Company) (incorporated by reference to Exhibit 4.3
                              of the 1996 8-K).

            5.1               Opinion of Boylan, Brown, Code, Fowler, Vigdor & 
                              Wilson, LLP.

            10.1              Securities  Purchase Agreement dated July 12, 1996
                              among PSC Inc.,  SpectraScan,  Inc. and  Equitable
                              Life  Assurance   Society  of  the  United  States
                              (separate   but  identical   Securities   Purchase
                              Agreements  were  addressed  to each of the  Other
                              Purchasers  of  the  Senior   Subordinated  Notes)
                              (incorporated  by reference to Exhibit 10.1 of the
                              1996 8-K).

            10.2              Amendment   No.  1  dated   October  10,  1996  to
                              Securities Purchase Agreements among PSC Inc., PSC
                              Scanning,   Inc.,  and  Equitable  Life  Assurance
                              Society  of  the  United   States   (separate  but
                              identical amendments were addressed to each of the
                              other purchasers of the Senior Subordinated Notes)
                              (incorporated  by reference to Exhibit 10.2 of the
                              Company's  Quarterly  Report  on Form 10-Q for the
                              quarter ended September 27, 1996).

            10.3             Amendment No. 2 and Waivers under Securities 
                             Purchase Agreements dated as of July 4, 1997 among 
                             PSC Inc., PSC Scanning, Inc. and the Purchasers 
                             named in the Securities Purchase Agreements 
                             (incorporated by reference to Exhibit 10.4 of the 
                             Company's Quarterly Report on Form 10-Q for the 
                             quarter ended July 4, 1997).

            10.4             Amendment No. 3 to Securities Purchase Agreements 
                             and Warrants dated as of August 18, 1997 among PSC 
                             Inc., PSC Scanning, Inc. and the Purchasers named
                             in the Securities Purchase Agreements 
                             (incorporated by reference to Exhibit
                             10.6 of the Company's report on Form 10-Q/A for 
                             the quarter ended July 4, 1997).

            23.1              Consent of Boylan, Brown, Code, Fowler, Vigdor & 
                              Wilson, LLP (contained in Exhibit 5.1 to the 
                              Registration Statement).

            23.2              Consent of Arthur Andersen LLP.

             24               Power of Attorney (included on Page II-4).

Item 17. Undertakings

                            Rule 415 Offering.  The undersigned registrant 
                            hereby undertakes:
 
                                    To file, during any period in which offers 
                            or sales are being made, a post-effective amendment 
                            to this registration statement;

                                            To include any material information 
                             with respect to the plan of distribution not 
                             previously disclosed in the registration statement 
                             or any material change to such information in the 
                             registration statement;

     that, for the purpose of determining any liability under the Securities Act
of  1933,  each  such  post-effective  amendment  shall  be  deemed  to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

<PAGE>



   To remove from registration by means of a post-effective amendment any of the
securities being registered which remain unsold at the termination of the 
offering.

   Incorporating Subsequent Exchange Act Documents by Reference. The undersigned
Registrant  hereby  undertakes  that, for purposes of determining  any liability
under the Act, each filing of the Registrant's annual report pursuant to section
13(a) or  section  15(d) of the  Securities  Exchange  Act of 1934  (and,  where
applicable,  each filing of an employee benefit plans' annual report pursuant to
section 15(d) of the Securities  Exchange Act of 1934) that is  incorporated  by
reference in the Registration Statement shall be deemed to be a new Registration
Statement relating to the securities  offered therein,  and the offering of such
securities  at that time shall be deemed to be the  initial  bona fide  offering
thereof.

  Indemnification for Liabilities Arising Under the Securities Act of 1933.  
Insofar as indemnification  for  liabilities  arising under the Securities Act 
of 1933 (the"Act") may be permitted to directors,  officers and  
controlling  persons of the Registrant pursuant to the foregoing  provisions,  
or otherwise,  the Registrant has been advised that in the opinion of the 
Securities  and Exchange  Commission such  indemnification  is against  
public policy as expressed in the Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the Registrant of expenses incurred
or paid by a director,  officer or  controlling  person of the Registrant in the
successful  defense of any action,  suit or proceeding) is asserted  against the
Registrant by any director, officer or controlling person in connection with the
securities registered, the Registrant will, unless in the opinion of its counsel
the  matter  has been  settled by  controlling  precedent,  submit to a court of
appropriate  jurisdiction  the question  whether such  indemnification  by it is
against  public policy as expressed in the Act and will be governed by the final
adjudication of such issue.



<PAGE>


                                   SIGNATURES

         Pursuant  to  the  requirement  of the  Securities  Act  of  1933,  the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and had duly caused this Registration
Statement  to be  signed  on  its  behalf  by  the  undersigned,  hereunto  duly
authorized in the City of Rochester, State of New York on August 29, 1997.

                                               PSC Inc.


                                      By: /s/ Robert C. Strandberg
                                          Robert C. Strandberg, President
                                          And Chief Executive Officer


                                POWER OF ATTORNEY

         KNOW  ALL MEN BY THESE  PRESENTS,  that  each  person  whose  signature
appears below constitutes and appoints ROBERT C. STRANDBERG,  ROBERT S. EHRLICH,
and   WILLIAM   J.   WOODARD,   or  any  one  of  them,   as  true  and   lawful
attorneys-in-fact, each with full power and authority to act as such without the
other,  and  with  full  power  of  substitution,  for  him  and in any  and all
capacities,  to sign any amendments to this Registration Statement,  and to file
the same, with exhibits  thereto,  and other documents in connection  therewith,
with the Securities and Exchange  Commission,  the undersigned  hereby ratifying
and confirming all that said attorneys-in-fact, or any of them or his substitute
or substitutes, shall do or cause to be done by virtue hereof.

         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
Registration  statement  has been signed below by the  following  persons in the
capacities and on the dates indicated.

         Signature                                   Title              Date

         /s/ Robert C. Strandberg        President and Chief     August 29, 1997
         Robert C. Strandberg            Executive Officer

         /s/ William J. Woodard          Vice President, Chief   August 29, 1997
         William J. Woodard              Financial Officer and
                                         Treasurer


         /s/ Scott D. Deverell           Controller (Principal   August 29, 1997
         Scott D. Deverell               Accounting Officer)


         _____________________      Chairman of the Board     August 29, 1997
         Robert S. Ehrlich


         /s/ Jay M. Eastman         Director                  August 29, 1997
         Jay M. Eastman


         /s/ James W. Henry         Director                  August 29, 1997
         James W. Henry


         /s/ Donald K. Hess         Director                  August 29, 1997
         Donald K. Hess


         /s/ Thomas J. Morgan       Director                  August 29, 1997
        Thomas J. Morgan


         /s/ James C. O'Shea        Director                  August 29, 1997
        James C. O'Shea


         /s/ Jack E. Rosenfeld      Director                   August 29, 1997
        Jack E. Rosenfeld


         /s/ Justin L. Vigdor       Director                   August 29, 1997
        Justin L. Vigdor




<PAGE>




                                 August 28, 1997



PSC Inc.
675 Basket Road
Webster, NY 14580


       RE:    PSC Inc. - Registration Statement on Form S-3


Gentlemen:

         We  have  acted  as  counsel  to  PSC  Inc.,  a  New  York  corporation
(hereinafter  called  the  "Company"),   in  connection  with  its  Registration
Statement on Form S-3, filed under the  Securities Act of 1933,  relating to the
proposed  distribution  of up to 975,000 common shares of the Company,  $.01 par
value  ("Common  Shares")  which  are  issuable  upon the  exercise  of  certain
outstanding  warrants (the  "Warrants") of the Company and which are proposed to
be sold from time to time by certain selling shareholders.

         In that  connection,  we have examined the Certificate of Incorporation
of the  Company,  as  amended,  the  by-laws of the  Company,  as  amended,  the
Warrants,  the  Registration  Statement,  and such other documents and corporate
records as we have deemed necessary or appropriate for purposes of this opinion.

         Based upon the foregoing, it is our opinion that:

         1.       The  Company has been duly  organized  and is a validly  
existing  corporation  in good  standing under the laws of the State of New 
York.

         2. All necessary action has been taken by the Board of Directors of the
Company to authorize the Warrants and the issuance and sale of the Common Shares
upon exercise of the Warrants.

         3. When  certificates  for Common  Shares have been  delivered  against
payment of the purchase  price  therefor  upon  exercise of the  Warrants,  such
Common Shares will be validly issued, fully paid and nonassessable.

         We hereby  consent to the filing of this  opinion as Exhibit 5.1 to the
above-referenced  Registration  Statement and to the reference  made to us under
the  caption  "Legal  Matters"  in  the  Prospectus   forming  a  part  of  such
Registration Statement.

                                             Very truly yours,
                                            BOYLAN, BROWN, CODE,
                                        FOWLER, VIGDOR & WILSON, LLP


<PAGE>















                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS



As independent  public  accountants,  we hereby consent to the  incorporation by
reference in this  registration  statement of our report dated  January 31, 1997
included in PSC Inc.'s Form 10-K for the year ended December 31, 1996 and to all
references to our Firm included in this registration statement.



Arthur Andersen LLP

Rochester, New York,
    August 28, 1997



<PAGE>

                                                         August 29, 1997

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC  20549

         RE:      PSC Inc. (the "Registrant")
                  675 Basket Road
                  Webster, NY  14580

Ladies and Gentlemen:

         We enclose  for  filing  pursuant  to the  Securities  Act of 1933,  as
amended  (the  "Act),  a  Registration  Statement  on Form S-3  relating  to the
proposed distribution of up to 975,000 common shares of the Registrant which are
issuable  upon the  exercise  of  certain  outstanding  warrants  and  which are
proposed to be sold from time to time by certain selling shareholders.

         The fee required for this filing has been paid in  accordance  with the
procedures  set  forth  in  Instructions   for  filing  Fees,  Rule  3a  of  the
Commission's Informal and Other Procedures.

         The criteria for filing a  Registration  Statement on Form S-3 has been
reviewed  by the  Registrant  and that form is deemed  by the  Registrant  to be
appropriate for this filing.

         Please  direct any comments or questions  you may have  concerning  the
Registrant's Registration Statement to the undersigned or to our attorney Martin
S. Weingarten at (716) 232-5300.

                                                 Very truly yours,


                                                  William J. Woodard
                                      Vice President and Chief Financial Officer








© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission